Immune-related adverse events caused by combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab for lung cancer
Takashi Nomizo(Takatsuki Red Cross Hospital), Hideo Kita(Takatsuki Red Cross Hospital), Mami Sonomura(Takatsuki Red Cross Hospital), Naoki Kanda(Jichi Medical University), Yasukiyo Nakamura(Takatsuki Red Cross Hospital), Hiroko Fukata(Takatsuki Red Cross Hospital), Haruka Yamamoto(Takatsuki Red Cross Hospital), Chihiro Watanabe(International Institute for Applied Systems Analysis), Aika Okuno(Takatsuki Red Cross Hospital), Tsunetaka Murayama(Takatsuki Red Cross Hospital)
Cited by 1
Related Papers
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells
|Oncogene|2004|306
Growth arrest‐specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway
|Molecular Carcinogenesis|2006|108
Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway
|Oncogene|2003|87
Expression of the REG IV gene in ulcerative colitis
|Laboratory Investigation|2007|79
Chiral separation of phenylalanine in ultrafiltration through DNA-immobilized chitosan membranes
|Journal of Membrane Science|2006|78